News
Card image cap

Clinical trial go-between Inato raises $20m

Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

News
Card image cap

GSK, Merck in endometrial cancer face-off

GSK and Merck & Co have both reported new clinical data with the PD-1 checkpoint inhibitors, seeking an edge in the first-line treatment of advanced endometrial cancer

Patients

News
Card image cap

Clinical trial go-between Inato raises $20m

Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t

R&D

News
Card image cap

Clinical trial go-between Inato raises $20m

Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t

Partner Content

R&D
Card image cap
Partner Content

Novel Nasal Formulation and Delivery Summit

Not only has the pandemic fuelled interest in new modalities research, but it has also triggered a renaissance of formulation approaches amongst biopharma to bring new wave of drug substances and t